Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 383.00p on 25-07-2025 at 18:30:07
Change -3.50p -0.91%
Buy 384.50p
Sell 381.00p
Last Trade: Buy 306.00 at 383.00p
Day's Volume: 66,975
Last Close: 383.00p
Open: 388.50p
ISIN: GB00BDFBVT43
Day's Range 380.00p - 389.50p
52wk Range: 232.50p - 455.00p
Market Capitalisation: £406.50m
VWAP: 385.83346p
Shares in Issue: 106.14m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 306 383.00p Automatic Execution
16:35:24 - 25-Jul-25
Sell* 93 383.00p Automatic Execution
16:35:24 - 25-Jul-25
Sell* 8,052 383.00p Uncrossing Trade
16:35:24 - 25-Jul-25
Sell* 45 382.00p Automatic Execution
16:29:51 - 25-Jul-25
Sell* 2 382.00p Automatic Execution
16:29:27 - 25-Jul-25
Sell* 1,200 383.31p Ordinary
16:25:25 - 25-Jul-25
Sell* 72 384.50p Automatic Execution
16:21:59 - 25-Jul-25
Sell* 104 384.50p Automatic Execution
16:21:59 - 25-Jul-25
Sell* 46 384.50p Automatic Execution
16:21:59 - 25-Jul-25
Sell* 65 385.00p Automatic Execution
16:20:19 - 25-Jul-25
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Jul 2025 (Fri) 388.50 389.50 380.00 383.00 66,975
24th Jul 2025 (Thu) 383.00 390.00 383.00 386.50 100,628
23rd Jul 2025 (Wed) 375.00 385.00 371.00 383.00 119,549
22nd Jul 2025 (Tue) 367.50 375.00 367.50 374.00 56,598
21st Jul 2025 (Mon) 369.50 375.00 368.50 375.00 96,278
18th Jul 2025 (Fri) 370.00 370.00 359.00 370.00 35,244
17th Jul 2025 (Thu) 368.00 369.00 362.50 362.50 52,512
16th Jul 2025 (Wed) 370.00 370.00 353.50 357.00 64,127
15th Jul 2025 (Tue) 371.50 371.50 362.00 362.50 87,556
14th Jul 2025 (Mon) 356.00 370.00 354.00 370.00 218,652
11th Jul 2025 (Fri) 353.50 365.00 349.50 352.00 200,808
10th Jul 2025 (Thu) 351.50 358.00 351.50 353.00 214,913
9th Jul 2025 (Wed) 349.00 355.00 344.00 347.50 172,104
8th Jul 2025 (Tue) 339.00 348.00 333.00 343.50 155,699
7th Jul 2025 (Mon) 338.50 338.50 335.00 335.00 77,365
4th Jul 2025 (Fri) 326.00 336.00 326.00 334.50 67,347
3rd Jul 2025 (Thu) 326.50 336.00 324.50 332.50 64,618
2nd Jul 2025 (Wed) 314.50 321.00 310.00 320.00 149,774
1st Jul 2025 (Tue) 314.50 318.50 314.00 318.50 59,036
30th Jun 2025 (Mon) 319.00 319.00 315.00 316.50 70,725
27th Jun 2025 (Fri) 320.50 323.50 314.00 316.00 199,151
26th Jun 2025 (Thu) 323.50 324.00 307.00 320.00 76,128
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
2nd Jul 2025 7:00 am RNS Director Declaration
1st Jul 2025 7:00 am RNS Block listing Interim Review
1st Jul 2025 7:00 am RNS Total Voting Rights
23rd Jun 2025 7:00 am RNS OXB completes acquisition of US subsidiary
17th Jun 2025 6:00 pm RNS Director/PDMR Shareholding
11th Jun 2025 6:02 pm RNS Result of Annual General Meeting
11th Jun 2025 7:02 am RNS AGM Update
10th Jun 2025 10:49 am RNS Holding(s) in Company
5th Jun 2025 7:00 am RNS Block Listing Application
3rd Jun 2025 7:00 am RNS-R OXB Launches Advisory Board
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

LONDON BROKER RATINGS: Citi resumes at Aviva at 'neutral'

15th Jul 2025 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

SMALL-CAP WINNERS & LOSERS: LMS Capital rises on capital return plan

8th Jul 2025 10:31

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

LONDON BROKER RATINGS: BofA raises Persimmon; Citi cuts Man Group

8th Jul 2025 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

Oxford BioMedica completes purchase of last 10% stake in US subsidiary

23rd Jun 2025 11:56

(Alliance News) - Oxford BioMedica PLC on Monday said it has completed the acquisition of the remaining 10% stake in its US subsidiary from Massachusetts, US-based biotechnology firm Q32 Bio Inc. Read More

Oxford BioMedica touts strong first-half momentum ahead of meeting

11th Jun 2025 10:55

(Alliance News) - Oxford BioMedica PLC reported "strong commercial momentum" during the first half of the year, in a statement ahead of its annual general meeting on Wednesday. Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value9,120.31
Change-18.06

Login to your account

Forgot Password?

Not Registered